共 50 条
- [43] Interstitial lung disease in systemic sclerosis: highlights REVUE DE MEDECINE INTERNE, 2021, 42 (10): : 10S3 - 10S8
- [46] Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects Inflammopharmacology, 2023, 31 : 2445 - 2449
- [47] Immunosuppression for interstitial lung disease in systemic sclerosis EUROPEAN RESPIRATORY REVIEW, 2013, 22 (129): : 236 - 243
- [48] Pathogenesis of interstitial lung disease in systemic sclerosis RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2024, 5 (03): : 141 - 151